A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin-Dependent Kinase Inhibitor, in Patients With Relapsed or Refractory Mantle Cell Lymphoma

Autor: Cassaday, Ryan D., Goy, Andre, Advani, Suresh, Chawla, Purvi, Nachankar, Rajesh, Gandhi, Mansi, Gopal, Ajay K.
Zdroj: In Clinical Lymphoma Myeloma and Leukemia July 2015 15(7):392-397
Databáze: ScienceDirect
Externí odkaz: